Wanbury
WANBURYNSE

Wanbury

₹282.709.80 (3.59%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
271.60
Today’s high
297.95
52 week low
161.50
52 week high
315.20
Open price
273.95
Previous close
272.90
Live volume
5,89,792
Lower circuit
218.35
Upper circuit
327.45

Fundamentals

Market Cap
₹959Cr
ROE
51.51%
P/E Ratio(TTM)
22.32
EPS(TTM)
12.30
P/B Ratio
12.38
Dividend Yield
0.00%
Industry P/E
34.37
Book Value
22.16
Debt to Equity
2.98
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹165
+1.33%
Profit (Cr)
₹21.70
+37.69%
050100150200
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-5%
3Y CAGR+6%
Profit growthValue
1Y (TTM)+7.0%
3Y CAGR-28%

About

Wanbury Limited is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (API) and Formulations. It is one of the world's largest producers of Metformin (anti-diabetic). The company successfully completed its first commercial shipment of high-potency anaesthetic APIs to the European market from its state-of-the-art Tanaku facility.;
Founded in
1988
NSE symbol
WANBURY

Shareholding Pattern

Mar '26
Dec '25
Sep '25
Jun '25
Mar '25
Retail And Others
58.40%
Promoters
39.76%
Foreign Institutions
1.84%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹8,513.00
-56.50 (0.66%)
L
    H
    21,391.38114.0724.51
    PfizerPFIZER
    ₹4,497.00
    +33.70 (0.76%)
    L
      H
      20,446.9528.34.86
      ₹1,461.00
      +24.40 (1.70%)
      L
        H
        19,867.0830.685.09
        ₹788.00
        +9.60 (1.23%)
        L
          H
          19,290.9932.423.79
          Livesquawk
          Wanbury Limited completes TGA inspection in Tanuku, Andhra Pradesh. Receives GMP certificate, enabling shipment of 3 additional APIs.
          Livesquawk
          Wanbury's Q3 EBITDA rose to ₹267M from ₹139M YoY, reflecting strong growth. Q3 EBITDA margin improved to 16.4% from 10.5% YoY, showcasing efficiency gains.
          2026
          29
          May
          Quarterly & Annual Result
          Release date
          14
          May
          Quarterly & Annual Result
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          4
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks